Displaying 61 to 80 of 90 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Morphotek Inc Biotechnology company focused on the generation of proprietary organisms for product discovery and development. |
United States | 31 Dec 2001 | N/A Initial investment. Round participant. Active |
|
|
|
Netuitive Inc Provider of real-time analysis software for business service management (BSM). |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Novomer Inc An emerging sustainable chemistry company pioneering a family of high performance, environmentally responsible polymers and chemical intermediates. |
United States | 7 Nov 2007 | Series A Initial investment. Round participant. Active |
|
|
|
NuVox Inc Integrated communications provider |
United States | N/A Initial investment. Round participant. Active |
||
|
|
Oasys Water Inc |
United States | 31 Dec 2009 | N/A Initial investment. Round participant. Active |
|
|
|
Ontogeny Inc A biotechnology company that aims to use developmental biology insights for regenerative medicine therapies. |
United States | 31 Dec 1994 | N/A Initial investment. Round participant. Active |
|
|
|
PerSeptive Biosystems Inc |
United States | 31 Dec 1991 | N/A |
|
|
|
Pervasis Therapeutics Inc A biotechnology company developing novel therapeutics to promote vascular repair. |
United States | 31 Dec 2003 | N/A |
|
|
|
Polatis Inc |
United States | N/A Active |
||
|
|
Quanterix Corp A company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology. |
United States | 31 Dec 2007 | N/A Initial investment. Round participant. Active |
|
|
|
Receptos Inc [] |
United States | 23 Nov 2009 | Series A |
|
|
|
Renovis Inc |
United States | 31 Dec 2000 | N/A Initial investment. Round participant. Active |
|
|
|
Resolvyx Pharmaceuticals Inc A biopharmaceutical company developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. |
United States | 31 Dec 2005 | N/A Initial investment. Round participant. Active |
|
|
|
Seahorse Bioscience Inc A developer of test and measurement equipment that is primarily used for cell assay tests in research laboratories. |
United States | 31 Dec 2001 | N/A Initial investment. Round participant. Active |
|
|
|
Selecta Biosciences Inc A biotechnology company developing a new class of synthetic nanoparticle vaccines. |
United States | 31 Dec 2008 | N/A Initial investment. Round participant. Active |
|
|
|
SiCortex Inc High-performance computing company. |
United States | 3 Oct 2006 | Series B Initial investment. Round participant. Active |
|
|
|
Somatogen Inc A biopharmaceutical company developing synthetic hemoglobin products for use in blood transfusion. |
United States | 31 Dec 1988 | N/A Initial investment. Round participant. Active |
|
|
|
Tangent Medical Technologies Inc |
United States | 31 Dec 2011 | N/A Initial investment. Round participant. Active |
|
|
|
Taris Biomedical Inc Specialty pharmaceutical company developing local minimally-invasive drug-device convergence products. |
United States | 31 Dec 2008 | N/A Initial investment. Round participant. Active |
|
|
|
Tetraphase Pharmaceuticals Inc A biopharmaceutical company utilizing a synthetic chemistry technology platform to treat drug-resistant bacterial infections. |
United States | 31 Dec 2006 | N/A Initial investment. Round participant. Active |